Imidazole with angiotensin II antagonist properties
US5322950A · kind A · utility
49Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1992 |
| Grant date | Jun 21, 1994 |
| Priority date | — |
| Expiry date | Dec 4, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to novel substituted imidazole and triazole derivatives which antagonize the binding of angiotensin II to its receptors. The compounds are useful in the treatment of hypertension, heart failure, glaucoma, and hyperaldosteronism. Methods of making the compounds, novel intermediates useful in the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of using them are also covered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.